Verrica Pharmaceuticals Inc. (VRCA) Total liabilities 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) total liabilities at each fiscal year-end, per SEC filings.
$22.4MFY2025 · since FY2021: $47.5M → $22.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.4M | -65.0% |
| FY2024 | $64.0M | +3.5% |
| FY2023 | $61.8M | +1219.0% |
| FY2022 | $4.7M | -90.1% |
| FY2021 | $47.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice